Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Glioblastoma | 21 | 2023 | 3523 | 0.980 |
Why?
|
Brain Neoplasms | 22 | 2023 | 9182 | 0.650 |
Why?
|
Drug Resistance, Neoplasm | 14 | 2023 | 5342 | 0.550 |
Why?
|
Fusion Proteins, bcr-abl | 7 | 2010 | 430 | 0.500 |
Why?
|
Ovarian Neoplasms | 11 | 2023 | 4906 | 0.440 |
Why?
|
Neoplastic Stem Cells | 5 | 2019 | 1357 | 0.360 |
Why?
|
Cell Line, Tumor | 33 | 2023 | 17149 | 0.350 |
Why?
|
Gene Expression Regulation, Neoplastic | 12 | 2022 | 8635 | 0.340 |
Why?
|
Oncolytic Virotherapy | 4 | 2023 | 521 | 0.340 |
Why?
|
Mice, Nude | 10 | 2024 | 3635 | 0.330 |
Why?
|
MicroRNAs | 8 | 2022 | 3805 | 0.320 |
Why?
|
Cell Movement | 10 | 2019 | 5223 | 0.320 |
Why?
|
Aldehyde Dehydrogenase | 2 | 2019 | 146 | 0.300 |
Why?
|
Lithium Chloride | 1 | 2008 | 83 | 0.300 |
Why?
|
Paclitaxel | 5 | 2022 | 1737 | 0.290 |
Why?
|
Antineoplastic Agents | 11 | 2023 | 13708 | 0.290 |
Why?
|
Glycogen Synthase Kinase 3 | 2 | 2011 | 414 | 0.290 |
Why?
|
Cisplatin | 5 | 2022 | 1661 | 0.290 |
Why?
|
Cytomegalovirus Infections | 3 | 2021 | 839 | 0.280 |
Why?
|
Glioma | 6 | 2013 | 3523 | 0.260 |
Why?
|
DNA Repair | 6 | 2010 | 2051 | 0.250 |
Why?
|
Exosomes | 3 | 2021 | 429 | 0.240 |
Why?
|
Spheroids, Cellular | 5 | 2023 | 332 | 0.230 |
Why?
|
Cell Proliferation | 12 | 2019 | 10494 | 0.230 |
Why?
|
Elasticity Imaging Techniques | 2 | 2020 | 391 | 0.230 |
Why?
|
Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 2 | 2010 | 687 | 0.220 |
Why?
|
Herpesvirus 1, Human | 2 | 2023 | 744 | 0.200 |
Why?
|
Cytomegalovirus | 2 | 2019 | 755 | 0.190 |
Why?
|
Immunotherapy | 5 | 2022 | 4728 | 0.190 |
Why?
|
Polyunsaturated Alkamides | 1 | 2021 | 29 | 0.190 |
Why?
|
Oncolytic Viruses | 2 | 2023 | 345 | 0.180 |
Why?
|
Neoplasm Proteins | 5 | 2019 | 3611 | 0.180 |
Why?
|
Benzodioxoles | 1 | 2021 | 75 | 0.180 |
Why?
|
Neoplasm Invasiveness | 8 | 2016 | 3637 | 0.180 |
Why?
|
Cell Adhesion | 5 | 2019 | 3103 | 0.170 |
Why?
|
Alkaloids | 1 | 2021 | 192 | 0.170 |
Why?
|
Reactive Oxygen Species | 2 | 2006 | 2150 | 0.170 |
Why?
|
Doxorubicin | 2 | 2024 | 2229 | 0.170 |
Why?
|
Receptor-Like Protein Tyrosine Phosphatases, Class 2 | 1 | 2019 | 21 | 0.170 |
Why?
|
Mice | 32 | 2024 | 82045 | 0.160 |
Why?
|
Drug Resistance, Multiple | 2 | 2017 | 255 | 0.160 |
Why?
|
Granulosa Cells | 1 | 2019 | 116 | 0.160 |
Why?
|
Protein-Lysine 6-Oxidase | 1 | 2018 | 56 | 0.160 |
Why?
|
Killer Cells, Natural | 2 | 2022 | 2209 | 0.160 |
Why?
|
DNA Damage | 6 | 2006 | 2461 | 0.150 |
Why?
|
Osmium | 1 | 2017 | 18 | 0.150 |
Why?
|
Indoles | 2 | 2024 | 1834 | 0.150 |
Why?
|
Xenograft Model Antitumor Assays | 4 | 2024 | 3619 | 0.150 |
Why?
|
Vault Ribonucleoprotein Particles | 1 | 2017 | 11 | 0.150 |
Why?
|
Neovascularization, Pathologic | 3 | 2019 | 2643 | 0.140 |
Why?
|
Cell Survival | 10 | 2021 | 5801 | 0.140 |
Why?
|
Polymers | 1 | 2024 | 1631 | 0.140 |
Why?
|
Tumor Escape | 1 | 2020 | 374 | 0.140 |
Why?
|
Proto-Oncogene Proteins c-met | 1 | 2021 | 568 | 0.140 |
Why?
|
Coordination Complexes | 1 | 2017 | 73 | 0.140 |
Why?
|
Cell Communication | 2 | 2021 | 1662 | 0.140 |
Why?
|
Automation | 1 | 2019 | 588 | 0.130 |
Why?
|
Animals | 38 | 2024 | 169418 | 0.130 |
Why?
|
Indolizines | 1 | 2016 | 30 | 0.130 |
Why?
|
Brefeldin A | 1 | 2016 | 68 | 0.130 |
Why?
|
Pericytes | 1 | 2019 | 299 | 0.130 |
Why?
|
TNF-Related Apoptosis-Inducing Ligand | 1 | 2017 | 195 | 0.130 |
Why?
|
Iron | 1 | 2024 | 1813 | 0.130 |
Why?
|
Collagen Type III | 3 | 2021 | 92 | 0.130 |
Why?
|
Cell Culture Techniques | 2 | 2021 | 1669 | 0.130 |
Why?
|
Retinal Dehydrogenase | 3 | 2021 | 78 | 0.130 |
Why?
|
Mice, Inbred BALB C | 1 | 2024 | 6241 | 0.130 |
Why?
|
Tunicamycin | 1 | 2015 | 109 | 0.120 |
Why?
|
Collagen Type I | 1 | 2018 | 620 | 0.120 |
Why?
|
Poly(ADP-ribose) Polymerases | 1 | 2017 | 427 | 0.120 |
Why?
|
Extracellular Matrix | 2 | 2020 | 1738 | 0.120 |
Why?
|
Tumor Microenvironment | 5 | 2023 | 3939 | 0.120 |
Why?
|
Oxidative Stress | 2 | 2024 | 3145 | 0.120 |
Why?
|
Extracellular Matrix Proteins | 2 | 2021 | 835 | 0.120 |
Why?
|
Antibodies, Bispecific | 1 | 2017 | 204 | 0.120 |
Why?
|
Dexamethasone | 1 | 2022 | 1965 | 0.110 |
Why?
|
Down-Regulation | 2 | 2019 | 2944 | 0.110 |
Why?
|
Neoplasms, Experimental | 1 | 2019 | 1232 | 0.110 |
Why?
|
Genomic Instability | 2 | 2010 | 714 | 0.110 |
Why?
|
Topotecan | 3 | 2019 | 131 | 0.110 |
Why?
|
Morphogenesis | 1 | 2017 | 747 | 0.110 |
Why?
|
Protein-Arginine N-Methyltransferases | 1 | 2014 | 129 | 0.110 |
Why?
|
RecQ Helicases | 2 | 2010 | 53 | 0.110 |
Why?
|
Suppression, Genetic | 1 | 2013 | 190 | 0.110 |
Why?
|
Nanoparticles | 1 | 2024 | 1986 | 0.100 |
Why?
|
Tumor Cells, Cultured | 4 | 2013 | 6135 | 0.100 |
Why?
|
Oligonucleotide Array Sequence Analysis | 5 | 2019 | 3794 | 0.100 |
Why?
|
Morpholines | 1 | 2016 | 583 | 0.100 |
Why?
|
NF-kappa B | 1 | 2021 | 2491 | 0.100 |
Why?
|
Piperidines | 1 | 2021 | 1664 | 0.100 |
Why?
|
Oocytes | 1 | 2017 | 1168 | 0.100 |
Why?
|
Glucocorticoids | 1 | 2022 | 2170 | 0.100 |
Why?
|
Enzyme Inhibitors | 2 | 2016 | 3734 | 0.100 |
Why?
|
Aminopyridines | 1 | 2016 | 578 | 0.100 |
Why?
|
Fibroblast Growth Factor 2 | 1 | 2013 | 595 | 0.100 |
Why?
|
STAT5 Transcription Factor | 1 | 2012 | 268 | 0.090 |
Why?
|
ATP-Binding Cassette Transporters | 1 | 2014 | 568 | 0.090 |
Why?
|
STAT3 Transcription Factor | 2 | 2013 | 873 | 0.090 |
Why?
|
Rad51 Recombinase | 3 | 2006 | 191 | 0.090 |
Why?
|
Ionic Liquids | 1 | 2010 | 11 | 0.090 |
Why?
|
Angiogenesis Inhibitors | 1 | 2020 | 2062 | 0.090 |
Why?
|
Neoplasms, Glandular and Epithelial | 1 | 2013 | 489 | 0.080 |
Why?
|
Exodeoxyribonucleases | 1 | 2010 | 191 | 0.080 |
Why?
|
Quaternary Ammonium Compounds | 1 | 2010 | 204 | 0.080 |
Why?
|
Gene Expression Profiling | 6 | 2022 | 9507 | 0.080 |
Why?
|
Cell Cycle | 3 | 2008 | 2942 | 0.080 |
Why?
|
T-Box Domain Proteins | 1 | 2012 | 473 | 0.080 |
Why?
|
Kidney | 1 | 2024 | 7064 | 0.080 |
Why?
|
Valproic Acid | 1 | 2012 | 443 | 0.080 |
Why?
|
Simplexvirus | 2 | 2012 | 805 | 0.080 |
Why?
|
Cysteine-Rich Protein 61 | 1 | 2008 | 39 | 0.080 |
Why?
|
Membrane Transport Proteins | 1 | 2014 | 1036 | 0.080 |
Why?
|
Phosphotransferases (Alcohol Group Acceptor) | 1 | 2010 | 435 | 0.080 |
Why?
|
Humans | 49 | 2024 | 768451 | 0.070 |
Why?
|
Recombination, Genetic | 4 | 2006 | 1526 | 0.070 |
Why?
|
Vascular Endothelial Growth Factor A | 2 | 2020 | 3520 | 0.070 |
Why?
|
Magnetic Resonance Imaging | 3 | 2020 | 36840 | 0.070 |
Why?
|
Histone Deacetylase Inhibitors | 1 | 2012 | 776 | 0.070 |
Why?
|
AMP-Activated Protein Kinases | 1 | 2010 | 598 | 0.070 |
Why?
|
Blotting, Western | 3 | 2008 | 5042 | 0.070 |
Why?
|
Immediate-Early Proteins | 1 | 2009 | 444 | 0.070 |
Why?
|
Organ Culture Techniques | 1 | 2008 | 796 | 0.070 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2017 | 3612 | 0.060 |
Why?
|
Up-Regulation | 4 | 2021 | 4138 | 0.060 |
Why?
|
Signal Transduction | 9 | 2017 | 23638 | 0.060 |
Why?
|
Combined Modality Therapy | 1 | 2018 | 8559 | 0.060 |
Why?
|
Phosphoproteins | 2 | 2006 | 2450 | 0.060 |
Why?
|
Optics and Photonics | 1 | 2007 | 307 | 0.060 |
Why?
|
Imaging, Three-Dimensional | 1 | 2019 | 4077 | 0.060 |
Why?
|
JC Virus | 1 | 2006 | 87 | 0.060 |
Why?
|
Antigens, Viral, Tumor | 1 | 2006 | 153 | 0.060 |
Why?
|
Transgenes | 1 | 2009 | 1015 | 0.060 |
Why?
|
Gastric Bypass | 1 | 2013 | 829 | 0.060 |
Why?
|
NIH 3T3 Cells | 2 | 2019 | 669 | 0.060 |
Why?
|
Comet Assay | 1 | 2004 | 75 | 0.060 |
Why?
|
Receptors, Cell Surface | 1 | 2013 | 2819 | 0.060 |
Why?
|
Interphase | 1 | 2004 | 227 | 0.060 |
Why?
|
Porosity | 1 | 2024 | 352 | 0.060 |
Why?
|
Hep G2 Cells | 1 | 2024 | 379 | 0.060 |
Why?
|
Tumor Suppressor Proteins | 1 | 2014 | 2819 | 0.050 |
Why?
|
Receptor, Insulin | 2 | 2006 | 838 | 0.050 |
Why?
|
Female | 22 | 2023 | 396943 | 0.050 |
Why?
|
Antigens, CD | 1 | 2013 | 4029 | 0.050 |
Why?
|
Blast Crisis | 1 | 2003 | 102 | 0.050 |
Why?
|
Melanoma | 1 | 2021 | 5740 | 0.050 |
Why?
|
Kynurenine | 1 | 2023 | 142 | 0.050 |
Why?
|
Gamma Rays | 2 | 2019 | 319 | 0.050 |
Why?
|
Stress, Physiological | 1 | 2010 | 1409 | 0.050 |
Why?
|
Carcinoma | 1 | 2013 | 2341 | 0.050 |
Why?
|
Gene Regulatory Networks | 2 | 2022 | 1755 | 0.050 |
Why?
|
Mutagenesis | 1 | 2006 | 1230 | 0.050 |
Why?
|
Skin Neoplasms | 1 | 2021 | 5891 | 0.050 |
Why?
|
Oximes | 1 | 2023 | 304 | 0.050 |
Why?
|
Blood Cells | 1 | 2003 | 308 | 0.050 |
Why?
|
RNA Interference | 3 | 2022 | 2832 | 0.050 |
Why?
|
Receptor, IGF Type 1 | 1 | 2003 | 384 | 0.050 |
Why?
|
Tryptophan | 1 | 2023 | 483 | 0.050 |
Why?
|
Protein-Tyrosine Kinases | 2 | 2010 | 2434 | 0.050 |
Why?
|
Neovascularization, Physiologic | 1 | 2008 | 1369 | 0.050 |
Why?
|
Adenosine Triphosphatases | 1 | 2005 | 842 | 0.050 |
Why?
|
Antibodies, Monoclonal | 1 | 2018 | 9263 | 0.050 |
Why?
|
Subtraction Technique | 1 | 2003 | 519 | 0.040 |
Why?
|
DNA Helicases | 1 | 2005 | 853 | 0.040 |
Why?
|
Length of Stay | 1 | 2013 | 6521 | 0.040 |
Why?
|
Gene Expression Regulation, Leukemic | 1 | 2003 | 656 | 0.040 |
Why?
|
Neoplasms | 2 | 2020 | 22386 | 0.040 |
Why?
|
Tumor Suppressor Protein p53 | 2 | 2014 | 2964 | 0.040 |
Why?
|
Leukemia | 2 | 2005 | 1527 | 0.040 |
Why?
|
Biological Transport | 2 | 2014 | 2089 | 0.040 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2009 | 1905 | 0.040 |
Why?
|
T-Lymphocytes | 3 | 2023 | 10273 | 0.040 |
Why?
|
Survival Analysis | 2 | 2023 | 10125 | 0.040 |
Why?
|
Phosphorylation | 3 | 2021 | 8332 | 0.040 |
Why?
|
RNA, Small Interfering | 3 | 2014 | 3437 | 0.040 |
Why?
|
Phosphotyrosine | 1 | 2019 | 458 | 0.040 |
Why?
|
HeLa Cells | 2 | 2017 | 3090 | 0.040 |
Why?
|
Repressor Proteins | 1 | 2008 | 2987 | 0.040 |
Why?
|
Receptors, TNF-Related Apoptosis-Inducing Ligand | 1 | 2017 | 58 | 0.040 |
Why?
|
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2019 | 506 | 0.040 |
Why?
|
HT29 Cells | 1 | 2017 | 192 | 0.030 |
Why?
|
Viscosity | 1 | 2017 | 336 | 0.030 |
Why?
|
Cell Nucleus | 1 | 2006 | 2889 | 0.030 |
Why?
|
Protein Processing, Post-Translational | 1 | 2004 | 1969 | 0.030 |
Why?
|
Platelet-Derived Growth Factor | 1 | 2019 | 617 | 0.030 |
Why?
|
Immunity | 1 | 2022 | 1002 | 0.030 |
Why?
|
HCT116 Cells | 1 | 2017 | 406 | 0.030 |
Why?
|
Proto-Oncogene Proteins | 1 | 2008 | 4534 | 0.030 |
Why?
|
Gene Expression | 3 | 2014 | 7605 | 0.030 |
Why?
|
Histone Demethylases | 1 | 2019 | 322 | 0.030 |
Why?
|
Lymphokines | 1 | 2019 | 927 | 0.030 |
Why?
|
Sus scrofa | 1 | 2017 | 430 | 0.030 |
Why?
|
Pancreatic Neoplasms | 1 | 2013 | 5442 | 0.030 |
Why?
|
Insulin-Like Growth Factor I | 1 | 2003 | 1943 | 0.030 |
Why?
|
Bone Marrow Cells | 1 | 2003 | 2415 | 0.030 |
Why?
|
Elasticity | 1 | 2017 | 658 | 0.030 |
Why?
|
Mutation | 6 | 2021 | 30243 | 0.030 |
Why?
|
Transplantation, Heterologous | 2 | 2016 | 2393 | 0.030 |
Why?
|
Colorectal Neoplasms | 1 | 2015 | 6978 | 0.030 |
Why?
|
Cells, Cultured | 3 | 2019 | 19041 | 0.030 |
Why?
|
Kaplan-Meier Estimate | 2 | 2017 | 6537 | 0.030 |
Why?
|
Protein Transport | 2 | 2016 | 1963 | 0.030 |
Why?
|
Cell Membrane | 1 | 2024 | 3664 | 0.030 |
Why?
|
Vimentin | 1 | 2016 | 257 | 0.030 |
Why?
|
Antineoplastic Agents, Alkylating | 1 | 2019 | 618 | 0.030 |
Why?
|
Dacarbazine | 1 | 2017 | 560 | 0.030 |
Why?
|
Transfection | 3 | 2010 | 5767 | 0.030 |
Why?
|
Neoplastic Cells, Circulating | 1 | 2021 | 958 | 0.030 |
Why?
|
Liver Neoplasms | 2 | 2024 | 4362 | 0.030 |
Why?
|
Molecular Targeted Therapy | 2 | 2017 | 2834 | 0.030 |
Why?
|
Phenotype | 4 | 2017 | 16712 | 0.030 |
Why?
|
Nuclear Proteins | 1 | 2008 | 5808 | 0.030 |
Why?
|
Myelin Sheath | 1 | 2017 | 653 | 0.030 |
Why?
|
Anastomosis, Roux-en-Y | 1 | 2013 | 86 | 0.030 |
Why?
|
Poland | 1 | 2013 | 197 | 0.030 |
Why?
|
Drug Screening Assays, Antitumor | 1 | 2016 | 720 | 0.030 |
Why?
|
Time Factors | 5 | 2017 | 40271 | 0.030 |
Why?
|
Enzyme Induction | 1 | 2013 | 455 | 0.030 |
Why?
|
Liver | 2 | 2024 | 7575 | 0.030 |
Why?
|
Transforming Growth Factor beta | 1 | 2021 | 2003 | 0.030 |
Why?
|
Hematopoietic Stem Cells | 1 | 2005 | 3408 | 0.030 |
Why?
|
Gene Expression Regulation, Enzymologic | 2 | 2010 | 1170 | 0.030 |
Why?
|
Models, Biological | 1 | 2009 | 9505 | 0.030 |
Why?
|
Neuroglia | 1 | 2019 | 961 | 0.030 |
Why?
|
Insulin Receptor Substrate Proteins | 2 | 2006 | 558 | 0.030 |
Why?
|
Glycosylation | 1 | 2015 | 1100 | 0.020 |
Why?
|
Adenocarcinoma, Clear Cell | 1 | 2013 | 219 | 0.020 |
Why?
|
Cell Migration Assays | 1 | 2011 | 22 | 0.020 |
Why?
|
Antibodies | 1 | 2020 | 2425 | 0.020 |
Why?
|
Cyclic S-Oxides | 1 | 2011 | 25 | 0.020 |
Why?
|
Enzyme Activation | 2 | 2010 | 3594 | 0.020 |
Why?
|
Cluster Analysis | 1 | 2019 | 2731 | 0.020 |
Why?
|
Drug Synergism | 1 | 2016 | 1765 | 0.020 |
Why?
|
Anthraquinones | 1 | 2011 | 41 | 0.020 |
Why?
|
Cell Death | 1 | 2017 | 1684 | 0.020 |
Why?
|
Base Sequence | 3 | 2009 | 12428 | 0.020 |
Why?
|
Myosin Type II | 1 | 2011 | 70 | 0.020 |
Why?
|
Gastroparesis | 1 | 2013 | 143 | 0.020 |
Why?
|
Gastric Emptying | 1 | 2013 | 246 | 0.020 |
Why?
|
Genetic Engineering | 1 | 2017 | 936 | 0.020 |
Why?
|
Polystyrenes | 1 | 2011 | 105 | 0.020 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 2 | 2009 | 4586 | 0.020 |
Why?
|
Nanofibers | 1 | 2011 | 68 | 0.020 |
Why?
|
Disease Progression | 2 | 2010 | 13655 | 0.020 |
Why?
|
Carcinoma, Endometrioid | 1 | 2013 | 276 | 0.020 |
Why?
|
Gene Silencing | 1 | 2017 | 1503 | 0.020 |
Why?
|
Toxicity Tests, Chronic | 1 | 2010 | 5 | 0.020 |
Why?
|
Annexin A5 | 1 | 2010 | 104 | 0.020 |
Why?
|
Disease Models, Animal | 3 | 2017 | 18388 | 0.020 |
Why?
|
Microtubules | 1 | 2016 | 1074 | 0.020 |
Why?
|
Neoplasm Transplantation | 1 | 2014 | 2017 | 0.020 |
Why?
|
DNA-Binding Proteins | 2 | 2005 | 9623 | 0.020 |
Why?
|
Computational Biology | 1 | 2022 | 3546 | 0.020 |
Why?
|
Adenocarcinoma, Mucinous | 1 | 2013 | 526 | 0.020 |
Why?
|
Cystadenocarcinoma, Serous | 1 | 2013 | 480 | 0.020 |
Why?
|
Blood-Brain Barrier | 1 | 2016 | 1034 | 0.020 |
Why?
|
Cell Line | 3 | 2012 | 15609 | 0.020 |
Why?
|
Gene Knockdown Techniques | 1 | 2014 | 1608 | 0.020 |
Why?
|
Digestive System | 1 | 2010 | 244 | 0.020 |
Why?
|
Inhibitory Concentration 50 | 1 | 2010 | 467 | 0.020 |
Why?
|
Blood Cell Count | 1 | 2010 | 402 | 0.020 |
Why?
|
Swine | 1 | 2019 | 5996 | 0.020 |
Why?
|
Neurons | 1 | 2008 | 9504 | 0.020 |
Why?
|
Reproducibility of Results | 2 | 2023 | 20231 | 0.020 |
Why?
|
Phantoms, Imaging | 1 | 2017 | 2528 | 0.020 |
Why?
|
Microcirculation | 1 | 2013 | 1282 | 0.020 |
Why?
|
Liver Function Tests | 1 | 2010 | 527 | 0.020 |
Why?
|
Histone Deacetylase 1 | 1 | 2009 | 133 | 0.020 |
Why?
|
RNA-Binding Proteins | 1 | 2017 | 1885 | 0.020 |
Why?
|
Glucose | 2 | 2010 | 4355 | 0.020 |
Why?
|
Cytotoxicity, Immunologic | 1 | 2012 | 1355 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2010 | 10784 | 0.020 |
Why?
|
COS Cells | 1 | 2010 | 1136 | 0.020 |
Why?
|
Blood Vessels | 1 | 2013 | 1112 | 0.020 |
Why?
|
Epidermal Growth Factor | 1 | 2010 | 699 | 0.020 |
Why?
|
Rats, Inbred F344 | 1 | 2008 | 826 | 0.020 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2013 | 3816 | 0.020 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2016 | 2884 | 0.020 |
Why?
|
Chemotaxis | 1 | 2009 | 601 | 0.020 |
Why?
|
Chromatin Immunoprecipitation | 1 | 2009 | 856 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-bcr | 1 | 2005 | 20 | 0.020 |
Why?
|
Prognosis | 2 | 2021 | 30028 | 0.020 |
Why?
|
DNA Breaks, Double-Stranded | 1 | 2010 | 614 | 0.020 |
Why?
|
Rats, Wistar | 1 | 2010 | 1891 | 0.020 |
Why?
|
Genes, abl | 1 | 2005 | 69 | 0.020 |
Why?
|
DNA, Antisense | 1 | 2005 | 44 | 0.020 |
Why?
|
Clinical Trials as Topic | 1 | 2021 | 8051 | 0.020 |
Why?
|
Membrane Proteins | 1 | 2022 | 7895 | 0.020 |
Why?
|
Epigenesis, Genetic | 1 | 2019 | 3826 | 0.020 |
Why?
|
Methylnitronitrosoguanidine | 1 | 2004 | 18 | 0.020 |
Why?
|
DNA, Neoplasm | 1 | 2010 | 1749 | 0.020 |
Why?
|
Virus Replication | 1 | 2013 | 2459 | 0.020 |
Why?
|
Oncogene Proteins v-abl | 1 | 2004 | 19 | 0.020 |
Why?
|
Calcium-Binding Proteins | 1 | 2010 | 1085 | 0.020 |
Why?
|
Organ Specificity | 1 | 2010 | 1972 | 0.020 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2010 | 1152 | 0.010 |
Why?
|
Organ Size | 1 | 2010 | 2268 | 0.010 |
Why?
|
Tissue Scaffolds | 1 | 2011 | 948 | 0.010 |
Why?
|
DNA Primers | 1 | 2009 | 2826 | 0.010 |
Why?
|
Histone Deacetylases | 1 | 2009 | 717 | 0.010 |
Why?
|
Chromosome Aberrations | 1 | 2010 | 1781 | 0.010 |
Why?
|
Brain Diseases | 1 | 2013 | 1553 | 0.010 |
Why?
|
Carrier Proteins | 1 | 2017 | 4948 | 0.010 |
Why?
|
Mutagens | 1 | 2004 | 181 | 0.010 |
Why?
|
Actins | 1 | 2011 | 2064 | 0.010 |
Why?
|
Dose-Response Relationship, Radiation | 1 | 2005 | 882 | 0.010 |
Why?
|
Interferon-gamma | 1 | 2012 | 3169 | 0.010 |
Why?
|
Cell Line, Transformed | 1 | 2004 | 868 | 0.010 |
Why?
|
Cell Count | 1 | 2007 | 1835 | 0.010 |
Why?
|
Protein Kinases | 1 | 2010 | 1608 | 0.010 |
Why?
|
Recovery of Function | 1 | 2013 | 2994 | 0.010 |
Why?
|
Adaptation, Physiological | 1 | 2010 | 1315 | 0.010 |
Why?
|
Molecular Sequence Data | 2 | 2006 | 17647 | 0.010 |
Why?
|
Rats | 2 | 2010 | 23839 | 0.010 |
Why?
|
Genotype | 1 | 2017 | 13047 | 0.010 |
Why?
|
Treatment Outcome | 2 | 2023 | 65409 | 0.010 |
Why?
|
Positron-Emission Tomography | 1 | 2019 | 6657 | 0.010 |
Why?
|
Antigens, Neoplasm | 1 | 2010 | 2003 | 0.010 |
Why?
|
Recombinant Fusion Proteins | 1 | 2010 | 3735 | 0.010 |
Why?
|
DNA, Viral | 1 | 2009 | 2206 | 0.010 |
Why?
|
Sulfonamides | 1 | 2011 | 1988 | 0.010 |
Why?
|
Leukemia, Myeloid | 1 | 2004 | 693 | 0.010 |
Why?
|
Sequence Alignment | 1 | 2006 | 2184 | 0.010 |
Why?
|
Microscopy, Confocal | 1 | 2007 | 1977 | 0.010 |
Why?
|
Mice, SCID | 1 | 2006 | 2633 | 0.010 |
Why?
|
Plasmids | 1 | 2005 | 2269 | 0.010 |
Why?
|
Benzamides | 1 | 2006 | 1381 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2013 | 11138 | 0.010 |
Why?
|
Oxidation-Reduction | 1 | 2006 | 2232 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2017 | 11674 | 0.010 |
Why?
|
Polymerase Chain Reaction | 1 | 2009 | 6091 | 0.010 |
Why?
|
Body Weight | 1 | 2010 | 4630 | 0.010 |
Why?
|
Palliative Care | 1 | 2013 | 3644 | 0.010 |
Why?
|
Microscopy, Fluorescence | 1 | 2005 | 2640 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2014 | 14480 | 0.010 |
Why?
|
Gene Deletion | 1 | 2005 | 2674 | 0.010 |
Why?
|
Kinetics | 1 | 2005 | 6348 | 0.010 |
Why?
|
Apoptosis | 1 | 2014 | 9526 | 0.010 |
Why?
|
DNA Mutational Analysis | 1 | 2005 | 4120 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2019 | 20762 | 0.010 |
Why?
|
Biopsy | 1 | 2007 | 6816 | 0.010 |
Why?
|
Piperazines | 1 | 2006 | 2546 | 0.010 |
Why?
|
Models, Genetic | 1 | 2004 | 3442 | 0.010 |
Why?
|
Pyrimidines | 1 | 2006 | 3050 | 0.010 |
Why?
|
Transcription Factors | 1 | 2013 | 12174 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2008 | 12813 | 0.010 |
Why?
|
Fibroblasts | 1 | 2003 | 4180 | 0.010 |
Why?
|
Models, Statistical | 1 | 2007 | 5103 | 0.010 |
Why?
|
Inflammation | 1 | 2012 | 10865 | 0.010 |
Why?
|
Lung | 1 | 2010 | 10090 | 0.010 |
Why?
|
Protein Binding | 1 | 2003 | 9376 | 0.010 |
Why?
|
Pregnancy | 1 | 2013 | 30179 | 0.010 |
Why?
|
DNA | 1 | 2004 | 7213 | 0.010 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2007 | 9066 | 0.010 |
Why?
|
Male | 3 | 2013 | 364781 | 0.010 |
Why?
|
Middle Aged | 2 | 2013 | 223418 | 0.010 |
Why?
|
Prospective Studies | 1 | 2013 | 54914 | 0.000 |
Why?
|
Algorithms | 1 | 2007 | 14158 | 0.000 |
Why?
|
Aged | 1 | 2013 | 171520 | 0.000 |
Why?
|